Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein. The lead application is a medical countermeasure for radiation exposure for civilian, military, first responder and astronaut/flight crew populations in addition to other defense and clinical indications. RLIP76 works though the oxidative stress pathway and is efficacious as both a prophylactic and mitigator by effluxing toxins from the cell.